VacciXcell will unveil the new and improved TideCell®, a revolutionary bioprocessing adherent bioreactor, which utilizes the tide motion principle for the upcoming World Vaccine and Immunotherapy Congress. This event will give an in-depth look at the advancements in the integration of innovative technologies and its impact on immunotherapy and vaccine development.

Explore TideCell® and its latest capabilities which includes the 12.5” HMI Siemens PLC-based monitoring and control structure, built-in weighing platform, and compressed air path that comes with double HEPA and VOC filters among others. TideCell and tide motion technology combined, perfectly solves the challenges during cell culture, especially when dealing with difficult viruses. Learn more about this state-of-the-art technology and what more VacciXcell can offer.